Anti-Bcl-2 antibody [E17] - BSA and Azide free
- BOND RX™ Validated
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(120 Publications)
Rabbit Recombinant Monoclonal Bcl-2 antibody. Carrier free. Suitable for IP, WB, IHC-P and reacts with Human samples. Cited in 120 publications.
View Alternative Names
Apoptosis regulator Bcl-2, BCL2
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] - BSA and Azide free (AB185002)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human B-cell lymphoma tissue labelling Bcl-2 with purified ab32124 at 1/250. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32124).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] - BSA and Azide free (AB185002)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human breast carcinoma tissue labelling Bcl-2 with unpurified ab32124 at 1/200 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32124).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] - BSA and Azide free (AB185002)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human B cell lymphoma tissue labelling Bcl-2 with unpurified ab32124.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32124).
- IHC-P
AbReview52227****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] - BSA and Azide free (AB185002)
Formaldehyde-fixed, paraffin-embedded human DLBCL U2932 cell line xenograft tissue stained for Bcl-2 using ab32124 at 1/200 dilution in immunohistochemical analysis, followed by Goat anti-Rabbit IgG Alexa Fluor® 555.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32124).
This image is courtesy of an anonymous Abreview.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] - BSA and Azide free (AB185002)
This data was developed using the same antibody clone in a different buffer formulation (ab32124). Tissue Microarrays for Anti-Bcl2 antibody [E17] using ab32124 in immunohistochemical analysis. This table provides a detailed overview of positive (tick mark) and negative (cross mark) staining per sample type tested. The sections were pretreated with heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins. The section was incubated with ab32124 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
- IHC-P
PubMed
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] - BSA and Azide free (AB185002)
Immunohistochemical analysis of Human salivary glands taken from patients with primary Sjögren's syndrome, staining Bcl-2 with unpurified ab32124.
Antigen retrieval was performed via heat mediation in a citrate buffer (pH 6). Sections were blocked using 2% BSA, 10% normal serum and permeabilized with 0.5% Triton X-100. Samples were incubated with primary antibody (1/100) for one hour at room temperature. An Alexa Fluor® 594-conjugated anti-rabbit IgG was used as the secondary antibody.
N.B. Panels B and D are higher magnifications of panels A and C, respectively.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32124).
Image from Szyszko EA et al. Arthritis Res Ther. 2011 Jan 7;13(1):R2. Fig 5.; doi:10.1186/ar3220; 7 January 2011 Arthritis Research & Therapy 2011 13:R2.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] - BSA and Azide free (AB185002)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32124).
Immunohistochemical analysis of formalin fixed paraffin embedded human lymphoma labelling Bcl-2 with ab32124 at a concentration of 1µg/ml.
The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.
ab32124 anti- Bcl-2 antibody [E17] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).
- IHC-P
PubMed
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] - BSA and Azide free (AB185002)
Bcl-2 expression determined by immunohistochemical analyses of the 4 human UM xenografts (between 3 to 5 tumors have been studied per condition).
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32124).
Image from Némati F et al. PLoS One. 2014;9(1):e80836. Fig 2.; doi: 10.1371/journal.pone.0080836.
- WB
Lab
Western blot - Anti-Bcl-2 antibody [E17] - BSA and Azide free (AB185002)
This data was developed using the same antibody clone in a different buffer formulation (ab32124).
Lanes 1 - 4 : Merged signal (red and green). Green - ab32124 observed at 26 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab32124 was shown to specifically react with BCL2 when BCL2 knockout samples were used. Wild-type and BCL2 knockout samples were subjected to SDS-PAGE. ab32124 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1000 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging. 3% milk used as blocking agent.
All lanes:
Western blot - Anti-Bcl-2 antibody [E17] - BSA and Azide free (ab185002)
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
BCL2 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa whole cell lysate at 20 µg
Lane 4:
THP-1 whole cell lysate at 20 µg
Predicted band size: 26 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-Bcl-2 antibody [E17] - BSA and Azide free (AB185002)
ab32124 (purified) at 1/30 immunoprecipitating Bcl-2 in Jurkat (human T cell leukemia cell line from peripheral blood) cell lysate (Lane 1). Lane 2 - PBS. For western blotting, a HRP-conjugated anti-rabbit IgG, specific to the non-reduced form of IgG was used as the secondary antibody (1/1500).
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32124).
All lanes:
Immunoprecipitation - Anti-Bcl-2 antibody [E17] (<a href='/en-us/products/primary-antibodies/bcl-2-antibody-e17-ab32124'>ab32124</a>)
Predicted band size: 26 kDa
Observed band size: 26 kDa
false
- WB
Lab
Western blot - Anti-Bcl-2 antibody [E17] - BSA and Azide free (AB185002)
This data was developed using the same antibody clone in a different buffer formulation (ab32124).
Lanes 1- 2 : Merged signal (red and green). Green - ab32124 observed at 26 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab32124 was shown to react with Bcl-2 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab255364 (knockout cell lysate ab263752) was used. Wild-type HeLa and BCL2 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab32124 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Bcl-2 antibody [E17] (<a href='/en-us/products/primary-antibodies/bcl-2-antibody-e17-ab32124'>ab32124</a>) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
BCL2 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human BCL2 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-bcl2-knockout-hela-cell-line-ab255364'>ab255364</a>)
Predicted band size: 26 kDa
Observed band size: 26 kDa
false
- WB
Lab
Western blot - Anti-Bcl-2 antibody [E17] - BSA and Azide free (AB185002)
Blocking buffer and concentration : 5% NFDM/TBST
Diluting buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-Bcl-2 antibody [E17] - BSA and Azide free (ab185002)
All lanes:
MCF-7 (human breast carcinoma) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>)
Predicted band size: 26 kDa
false
Exposure time: 3min
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-Bcl-2 antibody [E17] - BSA and Azide free (AB185002)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (7)
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Bcl-2 antibody [E17]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Bcl-2 antibody [E17]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Bcl-2 antibody [E17]
-
Anti-Bcl-2 antibody [E17]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-Bcl-2 antibody [E17]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Bcl-2 antibody [E17]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Bcl-2 antibody [E17]
Reactivity data
Product details
ab185002 is the carrier-free version of ab32124.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The role of Bcl-2 extends to maintaining cell survival and balancing apoptotic signals. It functions as an anti-apoptotic molecule within the cell primarily involved in forming complexes with pro-apoptotic members of the Bcl-2 family like Bax and Bak. These interactions prevent mitochondrial membrane permeabilization which is an important step in apoptotic signal transduction. As an important regulator of apoptosis Bcl-2 helps in cellular homeostasis and appropriate immune responses under physiological conditions.
Pathways
Bcl-2 plays a critical role in the intrinsic or mitochondrial pathway of apoptosis. Within this pathway Bcl-2 interacts with other proteins such as cytochrome c and APAF-1 to inhibit apoptosis. This pathway involves a network of Bcl-2 family proteins where Bcl-2's anti-apoptotic role counteracts the pro-apoptotic activity of proteins like Bax. These interactions help fine-tune the apoptotic response to various internal stimuli maintaining cellular integrity and function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (120)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 16:1669800 PubMed41063986
2025
Applications
Unspecified application
Species
Unspecified reactive species
Aging 15:12120-12135 PubMed37917013
2023
Applications
Unspecified application
Species
Unspecified reactive species
Inflammation 47:421-437 PubMed37898994
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology international 46:2018-2027 PubMed35989482
2022
Applications
Unspecified application
Species
Unspecified reactive species
Gut and liver 16:861-874 PubMed35686503
2022
Applications
Unspecified application
Species
Unspecified reactive species
Applied biochemistry and biotechnology 194:3819-3832 PubMed35524876
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 8:81 PubMed35210429
2022
Applications
WB
Species
Human
Bioengineered 13:4493-4516 PubMed35137671
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:803278 PubMed35127513
2022
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 9:1722 PubMed35071416
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com